Slowed gastric emptying reverses
While the body produces GLP-1 naturally, individuals with type 2 diabetes or obesity may have impaired GLP-1 responses, which makes it harder for them to control blood sugar and manage their weight
Its an unbelievable potential benefit because so many severe diseases [like cardiovascular disease, liver disease and chronic kidney disease] are associated with diabetes, says Dr
Its exciting that these diabetes medications may offer additional benefits, such as protecting brain health, said Serena Jingchuan Guo, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy at the University of Florida, in a news release
Make it automatic
Another study showed GLP-1 agonist use to be associated with lower risks for several substance use disorders." To view or add a comment, sign in A team of researchers from The National Institutes of Health (NIH), Copenhagen University Hospital, and international collaborators has reported the first evidence from a randomised controlled clinical trial showing that a GLP-1 receptor agonist may help reduce heavy drinking in people living with both #obesity and #alcohol use disorder